Skip to main content
US EQUITIES CLOSED CRYPTO 24/7
HALAL TRADING ROOM Sharia-screened signals
Screen a stock
TERMINAL
ST

STLNStockStarling Oncology, Inc.

Nasdaq Capital Market · Healthcare · US

$3.00 last close 2026-11-20
Open in terminalCompare
Price alert

Verdicts genuinely change. Free email alert the moment STLN's does — no target price to set, unlike a price alert.

Near limit Ratio screen, 1 of 7 decided standards passing. AAOIFI, Dow Jones Islamic are within 3 points of their line. Even if they all crossed, the majority verdict would stay Not compliant. What would change it

Sharia status
NOT COMPLIANT
Per our in-house ratio engine · assessed 2026-08-28
Assessed 2026-08-28
1 of 7 pass our own screen — the standards disagree
Purification 0.00% *HTR non-permissible income <0.01%
🕌Open research, not a fatwa — verify with your own scholar.

Trade setup

Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.

SEPARATE FROM SHARIAH
No trade setup shown — a stock that isn't cleanly Sharia-compliant never gets a bullish verdict here.

Trade plan

Posted with a stop, a target and the level that invalidates it. It resolves into the public record either way.

MEAN_REVERSION
Entry
$4.00
Stop
$2.80
Target
$5.97
Risk : Reward 1.6R

Why this signal?

The factors behind the read, each shown with the figure it rests on, including the ones pointing the other way.

Structure0 of 5 timeframes bullish · 95.7% aligned
VWAPPrice below VWAP ($3.35)
VolumeRelative volume 4.4× the 20-day average
Momentum10-day rate of change -11.1%

Starling Oncology, Inc. (STLN) is currently considered not halal (non-compliant), per our in-house ratio engine (last assessed 2026-08-28). See the full ratio breakdown and business-activity screen below for the reasoning.

⚠️ Financial ratios are only half the screen. A company whose core business is in an excluded sector — weapons/defense, alcohol, gambling, conventional (interest-based) finance, tobacco, pork, or adult entertainment — is non-compliant even if every debt and income ratio passes. So passing ratios below don't override this verdict; check the business-activity screen for the reason.

434 other Healthcare stocks pass this same screen. See compliant Healthcare stocks →

Market & analysts
Price target
$9.25
+208.3% · 4 analysts
Institutional own.
50.0%
of shares
Momentum (10d)
-11.1%
rate of change
SMC grade
C · 50
95.7% aligned
0.00% *
Purification ratio (secondary provider, uncertain)
<0.01%
Non-permissible income — HTR, from filings (2026-09-30)
C · 50
SMC grade — 95.7% timeframe alignment
-11.1%
Rate of change (10d)
$9.25
Price target (+208.3%) · 4 analysts
50.0%
Institutional ownership

How the status reached this point

Non-compliant since Nov 20, 2026

First seen by our daily status check on Nov 20, 2026; it read Not rated on Nov 19, 2026, so the change landed between those two checks.

$3.18 — last close we recorded while it was still Not rated, Nov 19, 2026

  • Nov 20, 2026 Not rated → Non-compliant1 of 7 decided standards pass; AAOIFI debt ratio 30.1%; figures as of Sep 30, 2026
  • Nov 17, 2026 Tracking began Nothing before this date is on record.

Read once a day from the status this page publishes, last on Nov 21, 2026. The per-methodology record is under “What changed, and when” in the in-house research.

Free email, sent when our compliance re-scan finds a change.

🕌 In-house Compliance Research

Computed from published company financials, balance sheet as of 2026-09-30. These ratios come from the issuer's own published statements rather than structured SEC data.

AAOIFI divides by the market cap: $324.3M as of 2026-11-20.

Business activity: cleared (no excluded categories detected)

AAOIFI Fail 2 of 3 ratios pass
RatioValueThresholdResult
Interest-bearing debt 30.13% 30.00% Fail(0.1pp over)
Interest-bearing investments 11.38% 30.00% Pass(18.6pp buffer)
Non-permissible income 0.00% 5.00% Pass(5.0pp buffer)
Usmani Fail 4 of 5 ratios pass
RatioValueThresholdResult
Interest-bearing debt 52.07% 33.00% Fail(19.1pp over)
Interest-bearing investments 19.65% 33.00% Pass(13.4pp buffer)
Non-liquid assets 48.04% at least 20.00% Pass(28.0pp above the floor)
Non-permissible income 0.00% 5.00% Pass(5.0pp buffer)
Net liquid assets per share $-26.1M under mkt cap $324.3M Pass
MSCI Fail 2 of 4 ratios pass
RatioValueThresholdResult
Interest-bearing debt 52.05% 33.33% Fail(18.7pp over)
Cash + interest-bearing securities 19.65% 33.33% Pass(13.7pp buffer)
Accounts receivable 51.96% 33.33% Fail(18.6pp over)
Non-permissible income 0.00% 5.00% Pass(5.0pp buffer)
FTSE Fail 2 of 4 ratios pass
RatioValueThresholdResult
Interest-bearing debt 38.62% 33.33% Fail(5.3pp over)
Cash + interest-bearing securities 19.65% 33.33% Pass(13.7pp buffer)
Accounts receivable 51.96% 50.00% Fail(2.0pp over)
Non-permissible income 0.00% 5.00% Pass(5.0pp buffer)
Dow Jones Islamic Market Pass 4 of 4 ratios pass

Scored against a trailing-average market cap (24-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 29.35% 33.00% Pass(3.7pp buffer)
Cash + interest-bearing securities 11.08% 33.00% Pass(21.9pp buffer)
Accounts receivable 18.22% 33.00% Pass(14.8pp buffer)
Non-permissible income 0.00% 5.00% Pass(5.0pp buffer)
S&P Shariah Fail 3 of 4 ratios pass

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 39.15% 33.00% Fail(6.1pp over)
Cash + interest-bearing securities 14.78% 49.00% Pass(34.2pp buffer)
Accounts receivable 24.30% 49.00% Pass(24.7pp buffer)
Non-permissible income 0.00% 5.00% Pass(5.0pp buffer)
MSCI M-Series Fail 3 of 4 ratios pass

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 39.15% 33.33% Fail(5.8pp over)
Cash + interest-bearing securities 14.78% 33.33% Pass(18.6pp buffer)
Accounts receivable 39.08% 49.00% Pass(9.9pp buffer)
Non-permissible income 0.00% 5.00% Pass(5.0pp buffer)

Research only, not investment advice. Thresholds are each standard-setter's published limits; a ratio marked “at least” is a floor, not a ceiling.

How close is it to flipping?

Every current reading against its own line, closest first. A verdict is only as durable as that distance.

Dow Jones Islamic Market (% of 24-mo avg market cap)debt ratio 3.7pts
AAOIFI Standard 21 (% of market cap)non permissible income ratio 5.0pts
Usmani (% of total assets)non permissible income ratio 5.0pts
Usmani (% of total assets)debt ratio 19.1pts
MSCI Islamic Index (% of total assets)debt ratio 18.7pts
MSCI Islamic Index (% of total assets)receivables ratio 18.6pts

The numbers the ratios are built from

Read from STLN's own filings. Every percentage on this page is one of these lines divided by another, so the inputs are shown rather than asserted.

LineFigureAs reportedRead from
RevenueTotal revenue for the period $502.7M 2026-09-30 RevenueFromContractWithCustomerExcludingAssessedTax
Interest-bearing debtShort and long-term borrowings $72.5M 2026-09-30 LongTermDebtNoncurrent
Cash and interest-bearing securitiesCash, equivalents and marketable securities $36.9M 2026-09-30 CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
Total assetsBalance sheet total $187.8M 2026-09-30 Assets
Market capDenominator for AAOIFI $324.3M live quote price x shares
36-month average market capDenominator for S&P Shariah and MSCI M-Series $242.7M 756 trading days closes x shares
24-month average market capDenominator for Dow Jones Islamic Market $325.5M 504 trading days closes x shares
Non-permissible revenueInterest and excluded income $0 2026-09-30 no interest-income tag reported in 3+ years (treated as $0)

Two dates, not one: a balance-sheet line and an income-statement line cover different windows by design, so each figure carries its own.

Sources

Filing information. Balance sheet: Quarterly report (10-Q) filed 2026-11-06, period ended 2026-09-30. Income statement: Annual report (10-K) filed 2026-03-12, period ended 2026-09-30. Screened 2026-11-20.

  • Total assets$187.8M
    Assets · period ended 2026-09-30 · 10-Q filed 2026-11-06
  • Interest-bearing debt$72.5M
    LongTermDebtNoncurrent · period ended 2026-09-30 · 10-Q filed 2026-11-06
  • Cash and interest-bearing securities$36.9M
    CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · period ended 2026-09-30 · 10-Q filed 2026-11-06
  • Receivables$60.7M
    AccountsReceivableNetCurrent · period ended 2026-09-30 · 10-Q filed 2026-11-06
  • Revenue$502.7M
    RevenueFromContractWithCustomerExcludingAssessedTax · period ended 2025-12-31 · 10-K filed 2026-03-12
  • Interest income (non-permissible)$0
    no interest-income tag reported in 3+ years (treated as $0) · income statement as of 2026-09-30 · no filing link for this figure
  • Market cap$324.3M
    Market quote passed in by the screen (Finnhub company profile; Yahoo Finance where Finnhub has none), 2026-11-20 · not a filing figure, so no link

5 reported values cited from 2 SEC filings, read from SEC's XBRL company facts when this symbol was screened. A link opens the filing's index on EDGAR.

What changed, and when

Verdict history for STLN. A verdict that never moved is recorded too, so a quiet history reads as measured rather than missing.

  • 2026-11-20 Unverified → Pass filing re-screen
  • 2026-11-20 Unverified → Fail filing re-screen
  • 2026-11-20 Pass → Fail filing re-screen

Tracked since 2026-09-07.

What would change the status

The headline verdict is the majority of the decided ratio standards — 1 pass and 6 fail of 7 — with a business-activity screen and any hold applied on top. Balance sheet as of 2026-09-30; market cap as stored on 2026-11-20.

Within 3 points of the line

AAOIFI, Dow Jones Islamic are within 3 points of their line. Even if they all crossed, the majority verdict would stay Not compliant.

The ratios that move with the share price

AAOIFI's debt ratio is $97.7M debt (operating leases included, as the screen counts it) over a market cap of $324.3M (as of 2026-11-20), 30.1% against a 30% line.

It would pass if the market cap rose above $325.8M (+0%), about $3.19 a share against $3.18 implied by the screen's own figures.

AAOIFI would then pass; the majority verdict would stay Not compliant (2 of 7 decided standards passing).

At the screen's market cap, it would take $430,565 less debt to clear the line.

AAOIFI would then pass; the majority verdict would stay Not compliant (2 of 7 decided standards passing, counting every standard that divides the same figure).

AAOIFI's investments ratio (11.4% against a 30% line) would only fail if the market cap fell by 62%, to $123.0M.

Only AAOIFI divides by the market cap itself. The Dow Jones, S&P and MSCI M-Series standards divide by a 24- or 36-month average and the others by total assets, so a day's price move does not reach them. Figures are the screen's own; the live market cap differs from the stored one.

Shariah-compliant alternatives

Compliant companies in Medical Care Facilities listed on the same market, largest first. Each is screened on its own; none carries a documented concern or a hold.

CompanyMarket capPrice, day
EHCEncompass Health Corp $11.9B —
ENSGEnsign Group Inc $10.5B —
CHEChemed Corp. $7.1B —
LFSTLifeStance Health Group Inc $4.6B —
NHCNational Healthcare Corp. $3.6B —

A dash means no fresh quote is cached for that symbol; this list does not fetch one.

Funds that hold STLN

None of the 247 funds whose filed holdings we currently hold can be shown owning STLN shares. That set is a fixed list of widely held index funds and Shariah funds, plus the funds our look-through has read most recently. It is not every fund that owns STLN.

Sorted by STLN’s share of each fund, from the fund’s latest SEC N-PORT filing. “Compliant by weight” is the share of the fund’s holdings our look-through screens compliant. A fund is listed only where its filing is mostly equity and names STLN once, so a bond is not counted as the shares; 1 more fund name STLN in a way we cannot separate from its bonds, and is not listed. Shariah funds are those with a recorded certification, on our halal ETF list, or named Shariah, Islamic, Halal or Sukuk.

Tracked investors holding STLN
InvestorFirmPositionWeightAs of
Ken Griffin Citadel Advisors $23M 0.0% 2026-09-30
Peter Brown Renaissance Technologies $7M 0.0% 2026-09-30
Israel Englander Millennium Management $4M 0.0% 2026-09-30
Steven Cohen Point72 Asset Management $3M 0.0% 2026-09-30
Paul Tudor Jones Tudor Investment Corp $1M 0.0% 2026-09-30
Jefferies Jefferies Financial Group $0M 0.0% 2026-09-30
Joel Greenblatt Gotham Asset Management $0M 0.0% 2026-09-30

From the most recent 13F on file. A 13F reports long US equity positions quarterly and in arrears — it is what a manager held on the report date, not what they hold today.

7.055.884.723.552.382025-11-242026-05-272026-11-20

Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset

Support & Resistance
S3
2.76
S2
2.96
S1
3.07
PIVOT
3.27
R1
3.38
R2
3.58
R3
3.69

Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.

Price Forecast

The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.

7-day expected range
1.62 – 5.18
±52.21% from 3.40, made 2026-11-18 · resolves 2026-11-25
STRONG SELL
from 19 indicators
78.6% of our last 30385 forecasts — across every instrument we forecast, not just this one — landed inside their stated range, and 53.9% called the direction correctly.

Technical Summary

Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.

STRONG SELL
19 indicators
OscillatorsNEUTRAL
3 buy · 1 neutral · 3 sell
Moving averagesSTRONG SELL
0 buy · 0 neutral · 12 sell
Every indicator, and what it reads
IndicatorValueSignal
RSI (14)26.50BUY
Stochastic %K (14)0.74BUY
CCI (20)-92.78NEUTRAL
Williams %R (14)-99.26BUY
MACD (12,26,9)-0.20SELL
ROC (10)-17.13SELL
Momentum (10)-0.62SELL
EMA (10)3.75SELL
SMA (10)3.61SELL
EMA (20)4.53SELL
SMA (20)4.93SELL
EMA (30)4.98SELL
SMA (30)5.52SELL
EMA (50)5.41SELL
SMA (50)5.93SELL
EMA (100)5.50SELL
SMA (100)5.87SELL
EMA (200)4.81SELL
SMA (200)4.80SELL

About Starling Oncology, Inc.

Healthcare · Medical Care Facilities

Starling Oncology, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The company offers physician services, in-house infusion, in-house specialty pharmacy, clinical trials, radiation therapy, and outpatient blood product transfusion services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance and support services. It also manages clinical trials and palliative care programs; operates combined community clinics and infusion suites; and operates a specialty pharmacy that includes both in-office and mail-order dispensing for complementary oral and self-injectable medications taken by patients concurrent with their in-office cancer therapies. It serves adult and senior cancer patients. The company was formerly known as The Oncology Institute, Inc. and changed its name to Starling Oncology, Inc. in August 2026. Starling Oncology, Inc. was founded in 2007 and is headquartered in Cerritos, California.

starlingoncology.com ↗

Background via Yahoo Finance — informational, not part of the verdict.

Latest Signal — 2026-11-10

MEAN REVERSION
Type
4.00
Entry
2.80
Stop
5.97
Target
WIN
Outcome · exit 4.34 (+8.50%)

Stop 2.80 Now 3.00 Target 5.97

Grade verdict

Average — needs more confirmation before sizing up

SMC — Top Down

Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.

TimeframeBiasBars
📅 Daily BEARISH 64
⏰ 4H BEARISH 43
🕐 1H BEARISH 98
⏱ 15-Min BEARISH 130
⏲ 5-Min RANGING 234

Momentum & Volume

Rate of change and relative volume against this symbol's own recent history. Momentum describes what price has done; it is not a claim about what it will do.

-11.1%
Rate of change (10d)
4.4×
Volume vs its 20-day average
-0.87
MACD (no fresh cross)

Peer Movement

How the rest of the sector moved over the same window. Context for a price move, never a cause of one.

Peer movement computing — it will appear here on its own.

Before you act on this

The questions worth asking about any verdict on this page, answered plainly.

Is this a fatwa?

No. HTR applies published screening standards to a company's own filings and shows the result under each one. It is research, not a religious ruling. For a ruling that applies to you, ask a qualified scholar.

Why can the standards disagree?

Because they measure different things. Some divide interest-bearing debt by market cap, others by total assets, and the thresholds differ too. The same filing can clear one line and cross another. HTR shows every verdict rather than averaging them into one label.

How often is this re-screened?

Ratios are recomputed when a new filing lands, and the whole watchlist is re-screened on a rolling basis. The date on the verdict above is the last time this symbol was actually recomputed, not the last time the page was built.

Do I need to purify dividends?

If a company earns some non-permissible income, many scholars hold that the same share of any dividend should be given away. The non-permissible income figure above is the number that calculation starts from — the purification calculator finishes it, showing the filing figures behind the ratio and both the proportional and the AAOIFI per-share convention.

Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.

Compare with

Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.

Peer screening computing — it will appear here on its own.

Insider Activity (90d)

Insider transactions reported in the last ninety days. Insiders sell for reasons that have nothing to do with a view, so a sale on its own is not a signal.

NO DATA   0 buys · 0 sells

COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE

The weekly CFTC Commitments of Traders report for the broad market it tracks, not for this symbol. Positioning context for the tape — it says nothing about this company.

NEUTRAL   report date 2026-11-17 · Asset managers net 895049 (-19081)

AI Summary

Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.